Mark Roschewski, MD, is a hematologist-oncologist and physician-scientist specializing in lymphoid malignancies. He is an Attending Physician at Memorial Sloan Kettering Cancer Center in New York City. His clinical practice centers on lymphoid cancers, biologically informed combination therapies, and investigator-initiated clinical trials for patients with complex hematologic conditions. His research focuses on liquid biopsy biomarkers such as circulating tumor DNA for disease monitoring, tumor evolution and risk stratification in lymphoid malignancies, and development of targeted therapies to improve precision treatment. He serves as Editor-in-Chief of the Annals of Lymphoma, is an adjunct professor of medicine at the Uniformed Services University of the Health Sciences, and leads multiple clinical trials as a principal investigator. Widely published and a frequent invited speaker, he is recognized for advancing translational research in lymphoma care. Roschewski earned his medical degree from the University of Nebraska Medical Center, completed internal medicine residency at Eisenhower Army Medical Center, and a hematology-oncology fellowship at Walter Reed Army Medical Center.
Attending Physician
2026 – present
Deputy Chief, Lymphoid Malignancies Brqnch
2013 – 2025
Medical School
1997 – 2001
Residency
Fellowship
2009